These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1304 related items for PubMed ID: 10321661

  • 1. Stress doses of hydrocortisone reverse hyperdynamic septic shock: a prospective, randomized, double-blind, single-center study.
    Briegel J, Forst H, Haller M, Schelling G, Kilger E, Kuprat G, Hemmer B, Hummel T, Lenhart A, Heyduck M, Stoll C, Peter K.
    Crit Care Med; 1999 Apr; 27(4):723-32. PubMed ID: 10321661
    [Abstract] [Full Text] [Related]

  • 2. Effect of stress doses of hydrocortisone on S-100B vs. interleukin-8 and polymorphonuclear elastase levels in human septic shock.
    Mussack T, Briegel J, Schelling G, Biberthaler P, Jochum M.
    Clin Chem Lab Med; 2005 Apr; 43(3):259-68. PubMed ID: 15843228
    [Abstract] [Full Text] [Related]

  • 3. Low-dose hydrocortisone improves shock reversal and reduces cytokine levels in early hyperdynamic septic shock.
    Oppert M, Schindler R, Husung C, Offermann K, Gräf KJ, Boenisch O, Barckow D, Frei U, Eckardt KU.
    Crit Care Med; 2005 Nov; 33(11):2457-64. PubMed ID: 16276166
    [Abstract] [Full Text] [Related]

  • 4. Low-dose hydrocortisone treatment for patients with septic shock: a pilot study comparing 3days with 7days.
    Huh JW, Choi HS, Lim CM, Koh Y, Oh YM, Shim TS, Lee SD, Kim WS, Kim DS, Hong SB.
    Respirology; 2011 Oct; 16(7):1088-95. PubMed ID: 21726354
    [Abstract] [Full Text] [Related]

  • 5. Cardiovascular effects of the nitric oxide synthase inhibitor NG-methyl-L-arginine hydrochloride (546C88) in patients with septic shock: results of a randomized, double-blind, placebo-controlled multicenter study (study no. 144-002).
    Watson D, Grover R, Anzueto A, Lorente J, Smithies M, Bellomo R, Guntupalli K, Grossman S, Donaldson J, Le Gall JR, Glaxo Wellcome International Septic Shock Study Group.
    Crit Care Med; 2004 Jan; 32(1):13-20. PubMed ID: 14707555
    [Abstract] [Full Text] [Related]

  • 6. Hemofiltration does not influence early S-100B serum levels in septic shock patients receiving stress doses of hydrocortisone or placebo.
    Mussack T, Briegel J, Schelling G, Jochum M.
    Eur J Med Res; 2005 Feb 28; 10(2):81-7. PubMed ID: 15817428
    [Abstract] [Full Text] [Related]

  • 7. Hemofiltrastion does not influence early S-100B serum levels in septic shock patients receiving stress doses of hydrocortisone or placebo.
    Mussack T, Briegel J, Schelling G, Jochum M.
    Eur J Med Res; 2005 Jan 28; 10(1):11-7. PubMed ID: 15737948
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Administration of the nitric oxide synthase inhibitor NG-methyl-L-arginine hydrochloride (546C88) by intravenous infusion for up to 72 hours can promote the resolution of shock in patients with severe sepsis: results of a randomized, double-blind, placebo-controlled multicenter study (study no. 144-002).
    Bakker J, Grover R, McLuckie A, Holzapfel L, Andersson J, Lodato R, Watson D, Grossman S, Donaldson J, Takala J, Glaxo Wellcome International Septic Shock Study Group.
    Crit Care Med; 2004 Jan 28; 32(1):1-12. PubMed ID: 14707554
    [Abstract] [Full Text] [Related]

  • 11. Hemodynamic effects of i.v. milrinone lactate in pediatric patients with septic shock. A prospective, double-blinded, randomized, placebo-controlled, interventional study.
    Barton P, Garcia J, Kouatli A, Kitchen L, Zorka A, Lindsay C, Lawless S, Giroir B.
    Chest; 1996 May 28; 109(5):1302-12. PubMed ID: 8625683
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Influence of N-acetylcysteine on indirect indicators of tissue oxygenation in septic shock patients: results from a prospective, randomized, double-blind study.
    Spies CD, Reinhart K, Witt I, Meier-Hellmann A, Hannemann L, Bredle DL, Schaffartzik W.
    Crit Care Med; 1994 Nov 28; 22(11):1738-46. PubMed ID: 7956276
    [Abstract] [Full Text] [Related]

  • 16. Effect of Hydrocortisone on Development of Shock Among Patients With Severe Sepsis: The HYPRESS Randomized Clinical Trial.
    Keh D, Trips E, Marx G, Wirtz SP, Abduljawwad E, Bercker S, Bogatsch H, Briegel J, Engel C, Gerlach H, Goldmann A, Kuhn SO, Hüter L, Meier-Hellmann A, Nierhaus A, Kluge S, Lehmke J, Loeffler M, Oppert M, Resener K, Schädler D, Schuerholz T, Simon P, Weiler N, Weyland A, Reinhart K, Brunkhorst FM, SepNet–Critical Care Trials Group.
    JAMA; 2016 Nov 01; 316(17):1775-1785. PubMed ID: 27695824
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Effect of Vitamin C, Hydrocortisone, and Thiamine vs Hydrocortisone Alone on Time Alive and Free of Vasopressor Support Among Patients With Septic Shock: The VITAMINS Randomized Clinical Trial.
    Fujii T, Luethi N, Young PJ, Frei DR, Eastwood GM, French CJ, Deane AM, Shehabi Y, Hajjar LA, Oliveira G, Udy AA, Orford N, Edney SJ, Hunt AL, Judd HL, Bitker L, Cioccari L, Naorungroj T, Yanase F, Bates S, McGain F, Hudson EP, Al-Bassam W, Dwivedi DB, Peppin C, McCracken P, Orosz J, Bailey M, Bellomo R, VITAMINS Trial Investigators.
    JAMA; 2020 Feb 04; 323(5):423-431. PubMed ID: 31950979
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 66.